Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
WEBINAR ENDED
Monday, May 11, 8:00 AM EDT · 4 hours

Commercialization I Workshop

May 11, 2020 at 08:00:00 AM · Eastern Time (US & Canada)
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Technical Director, Novel Cell Therapy Laboratory, Cell Manipulation Core Facility, Dana-Farber Cancer Institute
Dr. Shaw has over 10 years’ experience in gene therapy clinical trials. She received her PhD in Microbiology from the University of Alabama Birmingham where she studied the foamy virus envelope protein. She performed postdoctoral work in the lab of Donald Kohn at Children’s Hospital Los Angeles where she engineered lentivirus vectors. In 2009, she moved to the University of California Los Angeles and managed several early phase gene transfer clinical trials for severe combined immunodeficiency (SCID), including regulatory and cell manufacturing activities.
Dr. Shaw is currently the Technical Director of the Novel Cell Therapy Laboratory, Cell Manipulation Core Facility at Dana-Farber Cancer Center. The Novel Cell Therapy Lab develops and manufactures cellular products that are more than minimally manipulated and regulated under Investigative New Drug Applications.
Webinar hosting presenter
Regulator at Paul-Ehrlich-Institut, Germany
Co-opted member of CHMP, EMA
Member of CAT, EMA
Paediatrician
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts Commercialization I Workshop
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents
Commercialization_I_Workshop_Syllabus.pdf
Preview Download Added by Alex Wendland at 5:47 PM - Thursday - May 7, 2020